Tekla Capital Management LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,149,822
-2.7%
72,2250.0%0.04%
-10.4%
Q3 2022$1,182,000
+16.1%
72,2250.0%0.05%
+20.0%
Q2 2022$1,018,000
-41.8%
72,2250.0%0.04%
-34.4%
Q1 2022$1,749,000
+3.7%
72,2250.0%0.06%
+13.0%
Q4 2021$1,686,000
-79.2%
72,225
-78.2%
0.05%
-79.5%
Q2 2021$8,092,000
-5.5%
331,7890.0%0.26%
-10.5%
Q1 2021$8,560,000
-51.7%
331,7890.0%0.29%
-52.8%
Q4 2020$17,737,000
+71.5%
331,789
+32.3%
0.62%
+60.6%
Q3 2020$10,343,000
-14.9%
250,7430.0%0.39%
-16.2%
Q2 2020$12,154,000
+29.8%
250,743
+13.2%
0.46%
+9.5%
Q1 2020$9,363,000
+0.3%
221,599
+1.5%
0.42%
+19.8%
Q4 2019$9,338,000
+62.0%
218,283
+36.3%
0.35%
+40.6%
Q3 2019$5,764,000
+34.6%
160,1470.0%0.25%
+43.4%
Q2 2019$4,281,000
+52.2%
160,147
+52.9%
0.18%
+53.5%
Q1 2019$2,812,000
+44.6%
104,714
+11.8%
0.11%
+60.6%
Q3 2018$1,945,000
+35.9%
93,6890.0%0.07%
+31.5%
Q2 2018$1,431,000
-32.0%
93,6890.0%0.05%
-34.1%
Q1 2018$2,105,000
-71.6%
93,689
-61.9%
0.08%
-71.3%
Q4 2017$7,404,000
+129.7%
245,885
+119.9%
0.29%
+108.8%
Q4 2016$3,224,000
-9.3%
111,8000.0%0.14%0.0%
Q3 2016$3,556,000
-69.9%
111,800
-69.3%
0.14%
-71.6%
Q2 2016$11,802,000
-41.0%
363,585
-49.2%
0.48%
-43.4%
Q1 2016$20,000,000
-12.0%
715,299
+12.2%
0.85%
+3.3%
Q4 2015$22,727,000
+22.2%
637,500
+13.3%
0.82%
+23.2%
Q3 2015$18,602,000
+20.0%
562,500
+52.0%
0.67%
+19.3%
Q2 2015$15,496,000370,0000.56%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders